😃Proud and happy to serve as #ASE2024 #SoMe champion 🌟 I invite you to follow me and other brilliant colleagues listed below for more content from Portland! American Society of Echocardiography Antonio Carlos Leite de Barros Filho Ritu Thamman MD rafavidalperez Oung Savly, MD, FASE-Certified EACVI-CHD Dr. Purvi Parwani David H. Wiener, MD V.L.Sorrell, MD (@CASEfromASE EIC) #echofirst

secondary mitral regurgitation Moderated by Akhil Narang, MD & Renu gives her pearls #ASE2014 #echofirst Look at cresentric jet( not circular) Restricted posterior leaflet from old MI Use all parameters: 3D VC area New AI quantitates volumes without geometric assumptions

Do you deep phenotype coarctation? You should! Shaine Morris MD MPH inspirational Feigenbaum lecture! #ASE2024 🔺22q11.2 deletion conotruncal (BAV transverse arch hypoplasia) 🔺Left sided lesions Turner syndrome 🔺NODAL( direction genes) Left-sided lesions Laterality defects

Admittedly, self promotion, but I believe it's important! Use of DCD and HepC+ donors my expand donor pool available to ACHD patients without liability (in spite of longer ischemic time). Jonathan Menachem ACTION Kurt Schumacher Shelby Kutty, MD, PhD, MHCM pubmed.ncbi.nlm.nih.gov/38897425/

📢 Out now! Our study “Impaired Myocardial Work in Children with Hypertrophic Cardiomyopathy and Left Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging" is now published in #PediatricCardiology! Check out the full paper here: link.springer.com/article/10.100…

⚡️Just published: A new score to evaluate Pediatric ECG evaluations! 🌐 A multicenter collaborative network to provide training in interpretation of the pediatric ECG. 💯 Accuracy score is a reliable measure! Glenn Wetzel, MD-PhD 📖 Read now open access: rdcu.be/dMzpa

Large Mayo clinic experience with hemodynamics in #ACHD. Authors suggest novel #PH cutoffs in ACHD. Question is: what is normal and when does early intervention benefit (as PH drugs become less noxious)? Alexander (Sasha) Opotowsky Alexander Vd Bruaene Shelby Kutty, MD, PhD, MHCM pubmed.ncbi.nlm.nih.gov/38956982/

Oh so cool! This can be so useful in #ACHD. I will be eager for this tech to mature. I wonder ;how long batteries last given i2i communication must drain faster than simple pacing. Swati Garekar Alexander Vd Bruaene Shelby Kutty, MD, PhD, MHCM Ali N Zaidi, MD pubmed.ncbi.nlm.nih.gov/38973458/

📢 Our article has just been published in AMIA. 👨‍💻We simulate outcomes of patients enrolled in three trials according to a predictive allocation approach. 📄Link: doi.org/10.1093/jamia/… 🤝Great collaboration with Jef Van den Eynde Shelby Kutty, MD, PhD, MHCM and other co-authors.

In our study, we performed predictive allocation in 3 RCTS (positive, negative, and trial stopped for futility) in pediatric cardiology. ⚙️ The following pipeline was used to create individual prediction models for the respective outcomes.🔮 📄Link: doi.org/10.1093/jamia/…

✅ Using predictive allocation, we demonstrate absolute risk reductions (from 4 to 19%) compared to the RCT allocation and the “better therapy”. Accordingly, the NNTs for predictive allocation varied between 5 and 20❗️ 📄Link: doi.org/10.1093/jamia/…

🔥 Read now: Unsupervised #machinelearning identifies distinct phenotypic clusters in rTOF IJC Congenital Heart Disease 📈These phenotypes show differences in clinical profiles, cardiac remodeling, and intervention rates. 📄Open Access: doi.org/10.1016/j.ijcc… #ArtificialIntelligence #CardioTwitter

#Varices in #fontan patients. It's remarkable to me that these develop with near normal transhepatic gradient. How and who to screen remains a bit of a mystery to me. More data definitely needed. Shelby Kutty, MD, PhD, MHCM Swati Garekar Alexander (Sasha) Opotowsky pubmed.ncbi.nlm.nih.gov/39070956/

Very important topic: efficacy of #GDMT in #ACHD. Small sample and difficult to interpret data highlight a major gap in knowledge AND the difficulting in addressing the gap. As a community we need to address this! Alexander Vd Bruaene Shelby Kutty, MD, PhD, MHCM ACTION pubmed.ncbi.nlm.nih.gov/39098615/

Important data on #Fontan and #pregnancy. Rates of fetal loss of only 21% (lower than other studies I remember) and no adverse maternal outcomes. IUGR is a problem (predictably). More data coming! Anum Minhas Erin D. Michos, M.D. Shelby Kutty, MD, PhD, MHCM pubmed.ncbi.nlm.nih.gov/39134124/

Useful data for #ACHD providers. Geriatric ACHD! #TPVR has outcomes similar to SPVR in adults >40yo in this mixed (~50%ToF) PVR group from Emory School of Medicine. MV analysis likely limited by low event rates but sick=worse. Alexandra Frogoudaki Shelby Kutty, MD, PhD, MHCM pubmed.ncbi.nlm.nih.gov/39147304/

🔍 New Study: The association between obesity and cancer risk in individuals with cardiovascular disease (CVD) has been further clarified in JAHA funded by the AHA Science #SFRN. This #ARICCancer study followed 5,127 participants over 28 years to investigate how obesity

Competitive athletics in #BAV, likely safe and not associated with aortopathy or valve dysfunction compared to non-athletes. #exercise is so important! Don't limit your patients! Swati Garekar Alexander Vd Bruaene Shelby Kutty, MD, PhD, MHCM pubmed.ncbi.nlm.nih.gov/39153748/

Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA JAHA AHA Science Alvaro Alonso Ryan Harris Sagar A. Patel, MD University of Minnesota Anne Blaes Shelby Kutty, MD, PhD, MHCM Roberta Florido, MD, MHS International Cardio-Oncology Society We would like to inform you that your post has been successfully published on @Oncodaily. Thank you for sharing! oncodaily.com/insight/133089

our📝on Artificial Intelligence to Promote Racial & Ethnic Cardiovascular #HealthEquity Need meticulous data collection & thorough review of training datasets,rigorous testing & continuous surveillance of algorithms, need to promote diversity in AI workforce & engage